Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G5622-5 | 5 µg | $282 |
| LS-G5622-100 | 100 µg | $957 |
| LS-G5622-500 | 500 µg | $1,747 |
Human BLC / CXCL13 Protein (Recombinant) (aa23-109) - LS-G5622
Human BLC / CXCL13 Protein (Recombinant) (aa23-109) - LS-G5622
Description:
BLC / CXCL13 Protein LS-G5622 is a Recombinant Human BLC / CXCL13 produced in E. coli aa 23-109. It is biologically active. For Research Use Only
Toll Free North America
206-374-1102
206-374-1102For Research Use Only
Overview
Description:
BLC / CXCL13 Protein LS-G5622 is a Recombinant Human BLC / CXCL13 produced in E. coli aa 23-109. It is biologically active. For Research Use Only
Specifications
Type
Recombinant Protein
Target
BLC / CXCL13
Synonyms
CXCL13 | ANGIE | ANGIE2 | BLC | B cell-attracting chemokine 1 | BCA-1 | BCA1 | C-X-C motif chemokine 13 | SCYB13 | Small-inducible cytokine B13 | B lymphocyte chemoattractant | B-cell chemoattractant | B-cell-attracting chemokine 1 | B-lymphocyte chemoattractant | Blc chemoattractant | BLR1L | Chemoattractant blc | CXC chemokine BLC
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Region
aa 23-109
Predicted Molecular Weight
10.3 kDa
AA Sequence
VLEVYYTSLRCRCVQESSVFIPRRFIDRIQILPRGNGCPRKEIIVWKKNKSIVCVDPQAEWIQRMMEVLRKRSSSTLPVPVFKRKIP
Expression System
E. coli
Source Species
E. coli
Purification
Greater than 97% by SDS-PAGE and HPLC
Bio-Activity
Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human B cells is in a concentration range of 1.0-10 ng/ml.
Endotoxin
Not Tested
Presentation
Tris, 50% Glycerol
Reconstitution
Reconstitute in sterile distilled water to 0.1-1 mg/ml.
Storage
Short term: -20°C; Long term: -80°C; Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About BLC / CXCL13
Publications (0)
Customer Reviews (0)
Images
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Popular BLC / CXCL13 Proteins
Source:
E. coli
Tag:
His, N-Terminal
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/26/2024
Date Requested: 4/26/2024
